High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs.
暂无分享,去创建一个
[1] J. McMurray,et al. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care , 1998, BMJ.
[2] P. Krishnaswamy,et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. , 2001, American heart journal.
[3] E. Antman,et al. ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .
[4] Alan S Maisel,et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.
[5] D. Mant,et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study , 2000, BMJ : British Medical Journal.
[6] M. Sabatine,et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. , 2003, Journal of the American College of Cardiology.
[7] C. Lenfant. High blood pressure: some answers, new questions, continuing challenges. , 1996, JAMA.
[8] K. Dickstein. Natriuretic peptides in detection of heart failure , 1998, The Lancet.
[9] R. Vasan,et al. The progression from hypertension to congestive heart failure. , 1996, JAMA.
[10] Y. Yazaki,et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels. , 2000, Japanese heart journal.
[11] H. Tunstall-Pedoe,et al. Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.
[12] K. Nakao,et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.
[13] H. Hense,et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population , 2000, Journal of hypertension.
[14] Michihisa Jougasaki,et al. Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure , 1993, Circulation.
[15] J. Cleland,et al. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? , 1998, European heart journal.
[16] K. Nakao,et al. Molecular biology and biochemistry of the natriuretic peptide system , 1996 .